- Fee assured
- Verified this account
This healthcare professional let us know that they are currently available for:
- Face-to-face consultations
- Video consultations
- Phone consultations
Last updated: 12 Nov 2020
Dr Powrie was appointed a Consultant in Diabetes and Endocrinology at Guy's and St Thomas' Hospitals in 1997. He has worked full time at this institution ever since gathering a comprehensive, in depth experience in all aspects of this highly specialised subject.
In addition to this Dr Powrie was appointed head of the Department of Diabetes and Endocrinology in 1998 and continued to run this large multidisciplinary unit for 16 years making many innovative changes and advances in care ensuring that this service remained in the forefront of patient treatment.
This unit was, and remains one of the largest and most comprehensive specialist centres in the UK and receives many complex referrals, both from the UK, and abroad.
Dr Powrie's undergraduate training was at the University of Aberdeen and following post-graduate medical training moved to St Thomas’ Hospital to complete his specialist training and a Doctorate which was awarded in 1996. He was also awarded Fellowship of the Royal College of Physicians of both London and Edinburgh, both in the year 2000.
Dr Powrie is widely published and is and honorary senior lecturer with King's College London. He has written over 40 peer reviewed articles in specialist scientific journals and has an active ongoing research programme. He is a member of many learned societies including the Society for Endocrinology (UK), The Endocrine Society (US) and Diabetes UK. He is a reviewer for several national and international publications and is involved in all forms of teaching from medical students through to international specialist courses.
Throughout his career Dr Powrie has practiced general endocrinology and diabetes both at Guy’s and St Thomas’ and London Bridge Hospitals. He runs a specialist thyroid clinic which deals with overactive and underactive thyroid conditions as well as thyroid nodules, goitres and thyroid cancer. He also runs clinics which deal with all other forms of hormonal disorders in endocrinology including pituitary, adrenal, parathyroid, calcium disorders, ovarian and testicular disorders and general diabetes clinics.
Areas of interest
Thyroid; parathyroid; pituitary; adrenal; endocrine disorders of the testes and ovaries; calcium disorders; diabetes.
- London Bridge Hospital Website: http://www.londonbridgehospital.com/LBH/consultant-det/dr-jake-powrie/
Current NHS consultant posts held
Consultant and Honorary Senior Lecturer in Endocrinology at Guy's and St Thomas' NHS Foundation Trust, London
Ali M.A., Liu Y.-F., Arif S., Tatovic D., Shariff H., Gibson V.B., Yusuf N., Baptista R., Eichmann M., Petrov N., Heck S., Yang J.H.M., Tree T.I.M., Irma P.-A., Yeo L., Baumard L.R., Stenson R., Howell A., Clark A., Boult Z., Powrie J., Adams L., Wong F.S., Luzio S., Dunseath G., Green K., OKeefe A., Bayly G., Thorogood N., Andrews R., Leech N., Joseph F., Nair S., Seal S., Cheung H., Beam C., Hills R., Peakman M., Dayan C.M. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Science Translational Medicine. 9 (402) (no pagination), 2017.
Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, Kronenberg-Versteeg D, Eichmann M, Knight RR, Heck S, Powrie J, Bingley PJ, Dayan CM, Miles JJ, Sewell AK, Price DA, Peakman M. Beta-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes. 64(3):916-25, 2015 Mar.
V. Hopkins L. Luck S. Preston R. McGowan BM. Carroll PV. Powrie JK. The prevalence and natural history of pituitary hemorrhage in prolactinoma. J Clin Endocrinol Metab. 98(6):2362-7, 2013
Gu H, Luck S, Carroll P, Powrie J and Chambers J. Cardiac Valve Disease and Low-Dose Dopamine Agonist Therapy: An Artefact of Reporting Bias. Clin Endocrinol. 74(5):608-10, 2011
Leelarathna L, Breen B, Powrie J, Thomas S, Guzder R, McGowan B, Carroll P. Co-morbidities, management and clinical outcome of auto-immune Addison’s disease. Endocrine. 38:113-117, 2010.
Huda MSB, Athauda NB, The MM, Carroll PV and Powrie JK. Factors Determining the Remission of Microprolactinomas after Dopamine Agonist Withdrawal. Clin Endocrinol. 72:507-511, 2010
Tysome JR, Chandra A, Chang F, Puwanarajah P, Elliott M, Carroll P, Powrie J, Hubbard JG, Clarke S, Jeannon JP, Simo R. Improving prediction of malignancy of cytologically indeterminate thyroid nodules. British Journal of Surgery. 96:1400-5, 2009.
Leelarathna L, Powrie JK, Carroll PV. Thomas Addison's Disease after 154 years: Modern diagnostic perspectives on an old condition. QJM. 102: 569-73, 2009.
Powrie JK. Bassett EE. Rosen T. Jorgensen JO. Napoli R. Sacca L. Christiansen JS. Bengtsson BA. Sonksen PH. Detection of growth hormone abuse in sport. Growth Hormone & IGF Research. 17(3):220-6, 2007
Powrie, J.K. Chapter 12; Endocrine. In Essential Clinical Medicine, Symptoms, Diagnosis, Management. Gibson and Rees. Cambridge University Press. 2009
- MRCP Royal College of Physicians 1986
- B Med Biol Aberdeen University 1979
- MD Aberdeen University 1992
- MB ChB Aberdeen University 1982
- FRCP Royal College of Physicians (Edin) 1999
- FRCP Royal College of Physicians (London) 2000
Reference number 2609315
- The Shard, London Bridge Hospital
- 13:00 - 20:00
- 020 7234 2865
- The Shard, London Bridge Hospital
- 09:00 - 14:00
- 020 7234 2865
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.